Related Experiment Video
Updated: Jul 31, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Effects of weight reduction interventions by community pharmacists
Renee A Ahrens1, Matthew Hower, Al M Best
1Bernard J. Dunn School of Pharmacy, Shenandoah University, 1460 University Drive, Winchester, VA 22601, USA. rahrens@su.edu
Objective:
To compare a meal replacement (MR) program with a conventional reduced-calorie diet (RCD) for weight management using the pharmacy as the setting and the pharmacist as the point of contact for dietary advice.
Design:
Randomized, controlled, open-label trial.
Setting:
Travis Pharmacy in Shenandoah, Iowa.
Patients:
Ninety-five patients from southwestern iowa and southeastern Nebraska were enrolled, of whom 88 were considered eligible for comparison (by continuing through week 2 of the study).
Intervention:
Patients were randomized to an MR plan or a traditional RCD plan. Patients were followed for a 3-month period of active weight loss and a 10-week period of weight maintenance. Patients returned every 3 weeks for follow-up with the pharmacist, for a total of 13 visits.
Main Outcome Measure:
Weight changes.
Results:
During the active weight loss phase, the MR (n = 45) and RCD (n = 43) groups lost a significant amount of weight, although no significant difference was found between the groups (mean +/- standard error = 4.90 +/- 0.30 kg MR versus 4.30 +/- 0.30 kg RCD; P = .16). In the weight maintenance phase, the MR group lost 0.70 +/- 0.40 kg and the RCD group lost 0.90 +/- 0.40 kg (P = .60). Significant improvements were observed in waist circumference, systolic and diastolic blood pressure, and triglyceride levels. No significant changes were seen in high-density lipoprotein cholesterol or low-density lipoprotein cholesterol levels in either group.
Conclusion:
Successful weight management can be achieved in a pharmacy setting. Both MR and RCD programs were effective.
Related Concept Videos
Drug Dosing: Obese Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management
